SET Announcements
13 August 2021
Financial Statement Quarter 2/2021 (Reviewed)
Read More
13 August 2021
Resolution of Board meetings No. 4/2021, appointment of sub-committees
Read More
15 July 2021
Report of Utilization the Capital Increase from IPO (No. 4) ended on June 30, 2021
Read More
13 July 2021
The Company and its Subsidiary has been additional approved of Narcotics Substance Category 5, Hemp Only
Read More
02 July 2021
Approval of Narcotics Substance Category 5, Hemp Only
Read More
14 May 2021
Management Discussion and Analysis Quarter 1 Ending 31 Mar 2021 (amended)
Read More
14 May 2021
Management Discussion and Analysis Quarter 1 Ending 31 Mar 2021
Read More
14 May 2021
Financial Performance Quarter 1 (F45) (Reviewed)
Read More
14 May 2021
Financial Statement Quarter 1/2021 (Reviewed)
Read More
06 May 2021
Dissemination of the Minutes of the 2021 Shareholders'Annual General Meeting on the Company's Website
Read More
26 April 2021
Form to Report on Names of Members and Scope of Work of the Audit Committee (F24-1)
Read More
23 April 2021
Shareholders meeting's resolution
Read More